Always interesting when @kneufel2 cites your paper in a debate to refute your mentor's point. Haloperidol QTc risk potentially overblown. https://t.co/dTGwfTHNi7 #ADS2018 #delirium #deliriumresearch #patientsafety
RT @PharmDuprey: @kneufel2 I'll shamelessly plug my own research here. https://t.co/PyHXsgiu1L #ADS2018 #delirium #deliriumresearch #pati…
@kneufel2 I'll shamelessly plug my own research here. https://t.co/PyHXsgiu1L #ADS2018 #delirium #deliriumresearch #patientsafety
RT @icurehab: Low‑Dose IV Haloperidol is Not Associated with QTc Prolongation https://t.co/bbyKo9Ymi0 #icurehab
RT @icurehab: Low‑Dose IV Haloperidol is Not Associated with QTc Prolongation https://t.co/bbyKo9Ymi0 #icurehab
RT @icurehab: Low‑Dose IV Haloperidol is Not Associated with QTc Prolongation https://t.co/bbyKo9Ymi0 #icurehab
Low‑Dose IV Haloperidol is Not Associated with QTc Prolongation https://t.co/bbyKo9Ymi0 #icurehab
The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of an RCT. https://t.co/813ztTjLoc
Excited to announce the publication of our recent short research report in @yourICM #research #ICU https://t.co/813ztTjLoc
#IntensCareMedicine The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc anal... https://t.co/QEkPjHzL8P